Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06887205
Status
Recruiting
Apply to this trial

Conditions

  • Lymphadenectomy
  • Lymphatic Reconstruction

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Lymphovenous bypass (LVB) — PROCEDURE
    At the time of axillary lymph node dissection (ALND) or inguinal lymph node dissection (ILND) in the melanoma patient population.

Study Details

To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.

Key Dates

Start date
Jun 10, 2026
Status verified
Jun 2026
Primary completion
Sep 1, 2028
Completion
Sep 1, 2028

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Upper extremity group recieving ALND
    Participants will be recruited pre-operatively by their treating physicians.
  • Experimental: Lower extremity group getting ILND
    Participants will be recruited pre-operatively by their treating physicians.

Primary Outcome Measure

Safety and adverse events [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Ashleigh M Francis, MD
[email protected]
713-413-7451
Ashleigh M Francis, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies